划重点!屠呦呦团队、中国工程院院士在AI+医疗方面的干货

2019-09-02 徐悦 生物探索

2019年世界人工智能大会于8月29-31日在上海成功举办。作为重要的主题峰会之一的2019人工智能健康峰会以“智汇健康?预见未来”为主题,通过构建一个多元、开放、创新的全球性共享交流平台,就人工智能(AI)健康领域发展趋势、行业监管、创新技术、实践应用及投资风向等话题进行深入探讨。

2019年世界人工智能大会于8月29-31日在上海成功举办。作为重要的主题峰会之一的2019人工智能健康峰会以“智汇健康?预见未来”为主题,通过构建一个多元、开放、创新的全球性共享交流平台,就人工智能(AI)健康领域发展趋势、行业监管、创新技术、实践应用及投资风向等话题进行深入探讨。

医疗健康作为重大的民生问题,也是AI应用大展拳脚的领域。在此次会议期间自然也受到了海内外专家学者的热烈讨论。

我国AI医疗发展的五大趋势

在中国工程院院士潘云鹤教授看来,未来AI在医学领域的趋势主要有以下几个方面:

趋势一:人工智能影响企业正在不断崛起

AI深耕医疗影像多年,作为AI应用最久远的一个细分领域。AI影像系统可以帮助许多医生提高医技水平,而许多公司在技术的发展中做出了重要的支持。比如说深睿医疗,它用于胸片的AI工具,对肺癌的检测率达到了98%以上,远远高于人工;浙大邵逸夫医院用角膜炎图像智能识别,其人工智能的准确率已经超过80%,这一数字超过了96%的测试医生。

趋势二:新一代智能医疗硬件装备出现

以智能超声仪技术为例,它的优点在于利用AI软件,在扫描实时自动识别与标记可疑病灶,并对可疑处进行更细致的诊断流程。浙大孔德兴教授设计的智能超声仪以1分36秒的耗时,90%的准确率荣获2018年11月全国首届超声AI读片大赛的冠军。要抓住AI2.0技术与医学装备相结合,创造新一代智能医学装备的重要时机。

趋势三:跨媒体智能医学装备出现

跨媒体智能医学装备的基本技术模型为手眼系统+医生。比如说,杭州三坛医疗科技利用增强现实眼镜用于微创骨折复位的案例。此外,“智微天眼”模块化手术机器人以精准智能、降低辐射、功能灵活、操作便捷为特点逐步用于手术治疗。

趋势四:医学装备与服务+5G网络

不但要搞手机中的5G建设,而且要搞医疗装备的5G建设。如今我们已经可以进行远程核磁共振检查,在使用5G技术后,远程医疗就可以做的很好。5G有三个很重要的特征:宽频的传输有利于医学图像高分辨度地进行远程传输;海量接入、准时钟有利于医疗设备的远程控制和远程观测;高可靠、低延时的信号传输有利于远程医疗操作。

5G移动通信+医疗能够实时远程医疗服务,进行高端医疗资源共享,远程手术指导示教犹如专家亲临,精准引导高端影像导航,进行实时动态监控为安全保驾护航。

趋势五:探索医疗养新的经营模式

在人工智能、互联网、5G、云平台等新技术的加持下,我国的医疗诊断出现了新的模式。这一经营模式的技术模型,实际上是把智能设备和云平台结合在一起。并且把能急救车和药店都连在云平台,为医疗研究、教学和管理进行服务。这不仅能够减轻医疗工作者的负担,而且还能服务于病人与普通家庭。以微医云医疗数字平台为例,潘院士道出其本质就是:医疗数据中心+医保数据中心+医药数据中心。

最后,潘院士总结说:“AI融入将使医疗仪器大变,医疗保健的方式大变,医、药、保体系大变,医疗水平将极大提高,其影像深刻而系统,充满了机遇与挑战。

AI助力传统医药走向世界

诺贝尔生理学或医学奖获得者屠呦呦团队的核心成员、中国中医科学院青蒿素研究中心专家委员会副主任廖福龙教授则介绍了AI如何助力传统医药走向世界。

对于飞速发展的医疗健康行业而言,跨国合作是适应时代发展的一个环节,跨界的合作则是当前医疗领域主流的导向。人工技术的出现,恰好是医药行业跨领域合作的先导标志。人工智能的来临是医疗行业加速发展和飞速应用的很好契机。它能够帮助现有的技术发展与能力再提升。这对于青蒿素的深入研究而言,人工智能对青蒿素的应用机理和抗药性机理研究都是可以探讨的。

在医疗健康领域,尤其是传统医药与人工智能的交汇是创新点,这也使得健康行业迎来全新的机遇。在AI+医疗健康的主题背景下,人工智能不仅仅能够将现有的传统医药研发能力在医疗健康大环境下的科学技术得到前所未有的提升创新和发展,也能够大幅度地降低人力、物力和成本。解决医疗健康悬而未决的或日渐显现的难题。有利于为医疗健康产业和传统医药行业步入新的境界,带来值得期待的多米诺效应。这才是人工智能与医药行业结合的真谛所在。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1981795, encodeId=50c71981e9523, content=<a href='/topic/show?id=2fe72161bb' target=_blank style='color:#2F92EE;'>#AI+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2161, encryptionId=2fe72161bb, topicName=AI+医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Tue Dec 03 19:45:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688165, encodeId=c4a6168816538, content=<a href='/topic/show?id=6a8d4e950d4' target=_blank style='color:#2F92EE;'>#工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47950, encryptionId=6a8d4e950d4, topicName=工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b96328479830, createdName=ms5439512287675881, createdTime=Mon Apr 20 04:45:00 CST 2020, time=2020-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346679, encodeId=44fe13466e975, content=<a href='/topic/show?id=78c74e728f0' target=_blank style='color:#2F92EE;'>#屠呦呦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47728, encryptionId=78c74e728f0, topicName=屠呦呦)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=fengyqf, createdTime=Wed Sep 04 11:45:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500859, encodeId=ddec150085977, content=<a href='/topic/show?id=ccc42182eab' target=_blank style='color:#2F92EE;'>#中国工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21827, encryptionId=ccc42182eab, topicName=中国工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc939466478, createdName=wumeihua91, createdTime=Wed Sep 04 11:45:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372239, encodeId=07a03e223958, content=科技助力医疗发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Wed Sep 04 06:33:45 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049129, encodeId=68ab104912919, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Sep 02 23:45:00 CST 2019, time=2019-09-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1981795, encodeId=50c71981e9523, content=<a href='/topic/show?id=2fe72161bb' target=_blank style='color:#2F92EE;'>#AI+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2161, encryptionId=2fe72161bb, topicName=AI+医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Tue Dec 03 19:45:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688165, encodeId=c4a6168816538, content=<a href='/topic/show?id=6a8d4e950d4' target=_blank style='color:#2F92EE;'>#工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47950, encryptionId=6a8d4e950d4, topicName=工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b96328479830, createdName=ms5439512287675881, createdTime=Mon Apr 20 04:45:00 CST 2020, time=2020-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346679, encodeId=44fe13466e975, content=<a href='/topic/show?id=78c74e728f0' target=_blank style='color:#2F92EE;'>#屠呦呦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47728, encryptionId=78c74e728f0, topicName=屠呦呦)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=fengyqf, createdTime=Wed Sep 04 11:45:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500859, encodeId=ddec150085977, content=<a href='/topic/show?id=ccc42182eab' target=_blank style='color:#2F92EE;'>#中国工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21827, encryptionId=ccc42182eab, topicName=中国工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc939466478, createdName=wumeihua91, createdTime=Wed Sep 04 11:45:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372239, encodeId=07a03e223958, content=科技助力医疗发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Wed Sep 04 06:33:45 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049129, encodeId=68ab104912919, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Sep 02 23:45:00 CST 2019, time=2019-09-02, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1981795, encodeId=50c71981e9523, content=<a href='/topic/show?id=2fe72161bb' target=_blank style='color:#2F92EE;'>#AI+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2161, encryptionId=2fe72161bb, topicName=AI+医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Tue Dec 03 19:45:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688165, encodeId=c4a6168816538, content=<a href='/topic/show?id=6a8d4e950d4' target=_blank style='color:#2F92EE;'>#工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47950, encryptionId=6a8d4e950d4, topicName=工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b96328479830, createdName=ms5439512287675881, createdTime=Mon Apr 20 04:45:00 CST 2020, time=2020-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346679, encodeId=44fe13466e975, content=<a href='/topic/show?id=78c74e728f0' target=_blank style='color:#2F92EE;'>#屠呦呦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47728, encryptionId=78c74e728f0, topicName=屠呦呦)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=fengyqf, createdTime=Wed Sep 04 11:45:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500859, encodeId=ddec150085977, content=<a href='/topic/show?id=ccc42182eab' target=_blank style='color:#2F92EE;'>#中国工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21827, encryptionId=ccc42182eab, topicName=中国工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc939466478, createdName=wumeihua91, createdTime=Wed Sep 04 11:45:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372239, encodeId=07a03e223958, content=科技助力医疗发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Wed Sep 04 06:33:45 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049129, encodeId=68ab104912919, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Sep 02 23:45:00 CST 2019, time=2019-09-02, status=1, ipAttribution=)]
    2019-09-04 fengyqf
  4. [GetPortalCommentsPageByObjectIdResponse(id=1981795, encodeId=50c71981e9523, content=<a href='/topic/show?id=2fe72161bb' target=_blank style='color:#2F92EE;'>#AI+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2161, encryptionId=2fe72161bb, topicName=AI+医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Tue Dec 03 19:45:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688165, encodeId=c4a6168816538, content=<a href='/topic/show?id=6a8d4e950d4' target=_blank style='color:#2F92EE;'>#工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47950, encryptionId=6a8d4e950d4, topicName=工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b96328479830, createdName=ms5439512287675881, createdTime=Mon Apr 20 04:45:00 CST 2020, time=2020-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346679, encodeId=44fe13466e975, content=<a href='/topic/show?id=78c74e728f0' target=_blank style='color:#2F92EE;'>#屠呦呦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47728, encryptionId=78c74e728f0, topicName=屠呦呦)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=fengyqf, createdTime=Wed Sep 04 11:45:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500859, encodeId=ddec150085977, content=<a href='/topic/show?id=ccc42182eab' target=_blank style='color:#2F92EE;'>#中国工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21827, encryptionId=ccc42182eab, topicName=中国工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc939466478, createdName=wumeihua91, createdTime=Wed Sep 04 11:45:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372239, encodeId=07a03e223958, content=科技助力医疗发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Wed Sep 04 06:33:45 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049129, encodeId=68ab104912919, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Sep 02 23:45:00 CST 2019, time=2019-09-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1981795, encodeId=50c71981e9523, content=<a href='/topic/show?id=2fe72161bb' target=_blank style='color:#2F92EE;'>#AI+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2161, encryptionId=2fe72161bb, topicName=AI+医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Tue Dec 03 19:45:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688165, encodeId=c4a6168816538, content=<a href='/topic/show?id=6a8d4e950d4' target=_blank style='color:#2F92EE;'>#工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47950, encryptionId=6a8d4e950d4, topicName=工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b96328479830, createdName=ms5439512287675881, createdTime=Mon Apr 20 04:45:00 CST 2020, time=2020-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346679, encodeId=44fe13466e975, content=<a href='/topic/show?id=78c74e728f0' target=_blank style='color:#2F92EE;'>#屠呦呦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47728, encryptionId=78c74e728f0, topicName=屠呦呦)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=fengyqf, createdTime=Wed Sep 04 11:45:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500859, encodeId=ddec150085977, content=<a href='/topic/show?id=ccc42182eab' target=_blank style='color:#2F92EE;'>#中国工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21827, encryptionId=ccc42182eab, topicName=中国工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc939466478, createdName=wumeihua91, createdTime=Wed Sep 04 11:45:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372239, encodeId=07a03e223958, content=科技助力医疗发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Wed Sep 04 06:33:45 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049129, encodeId=68ab104912919, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Sep 02 23:45:00 CST 2019, time=2019-09-02, status=1, ipAttribution=)]
    2019-09-04 Dr Z

    科技助力医疗发展

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1981795, encodeId=50c71981e9523, content=<a href='/topic/show?id=2fe72161bb' target=_blank style='color:#2F92EE;'>#AI+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2161, encryptionId=2fe72161bb, topicName=AI+医疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Tue Dec 03 19:45:00 CST 2019, time=2019-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688165, encodeId=c4a6168816538, content=<a href='/topic/show?id=6a8d4e950d4' target=_blank style='color:#2F92EE;'>#工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47950, encryptionId=6a8d4e950d4, topicName=工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b96328479830, createdName=ms5439512287675881, createdTime=Mon Apr 20 04:45:00 CST 2020, time=2020-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1346679, encodeId=44fe13466e975, content=<a href='/topic/show?id=78c74e728f0' target=_blank style='color:#2F92EE;'>#屠呦呦#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47728, encryptionId=78c74e728f0, topicName=屠呦呦)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=fengyqf, createdTime=Wed Sep 04 11:45:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1500859, encodeId=ddec150085977, content=<a href='/topic/show?id=ccc42182eab' target=_blank style='color:#2F92EE;'>#中国工程院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21827, encryptionId=ccc42182eab, topicName=中国工程院)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc939466478, createdName=wumeihua91, createdTime=Wed Sep 04 11:45:00 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=372239, encodeId=07a03e223958, content=科技助力医疗发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Wed Sep 04 06:33:45 CST 2019, time=2019-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049129, encodeId=68ab104912919, content=院士是学术至高点,也是大家必争之地呀, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Mon Sep 02 23:45:00 CST 2019, time=2019-09-02, status=1, ipAttribution=)]
    2019-09-02 junJUN

    院士是学术至高点,也是大家必争之地呀

    0

相关资讯

余艳红看望优秀共产党员屠呦呦

“今天是党的生日,您是共产党员的杰出代表,我代表国家中医药管理局党组向您,并通过您向中医药系统的老专家、老党员表示衷心感谢并致以崇高敬意!”

屠呦呦团队成员:可用AI分析望闻问切,提高中医诊疗精准度

8月29日-31日,2019世界人工智能大会在上海举行。诺贝尔奖获得者屠呦呦的团队成员、中国中医科学院青蒿素研究中心学术委员会副主任廖福龙出席了2019全球人工智能健康峰会,并在大会上发言。廖福龙表示,人工智能的来临已成为医疗健康行业加速发展与技术更新的重要机遇。同时,人工智能技术运用于青蒿素作用机理和抗药机理的研究与解读,也可助力于青蒿素的深入研究。会后,廖福龙接受了澎湃新闻(www.thepa

屠呦呦团队突破青蒿素抗药性难题!与昆药集团深度合作

;">资料图 屠呦呦 屠呦呦:青蒿素依然是抗疟首选药物 过去20余年间,青蒿素联合疗法在全球疟疾流行地区广泛使用。据世卫组织不完全统计,青蒿素在全世界已挽救了数百万人的生命,每年治疗患者上亿人。 “青蒿素抗疟药价格低廉,每个疗程仅需几美元,适用于疫区集中的非洲广大贫困地区人群。”屠呦呦说,“聚焦研发廉价青蒿素抗疟药有助于实现全球消灭疟疾的目标。”

光环下的屠呦呦在想些什么

得知获得国家最高科学技术奖后,屠呦呦很淡定。这种淡定,和她在得知自己获得诺贝尔奖时的心情有点类似。2015年,因为获得诺奖,屠呦呦成了中国一张闪亮的科技名片。自那之后,这位年逾八旬的老人,突然之间,被推进了舆论场的中心地带。采访、座谈、慰问,“明星”的光环与喧嚣让老人不太适应。“关于奖项,屠老师不太关注”80多岁的姜廷良坐在座位上,身体前倾,以便能离话筒近一些,更清晰地向在坐的记者朋友们讲述屠

屠呦呦亲笔信:“中国传统医药献给人类的礼物”是怎么发现的

中医药是5000多年中华文明的结晶,在人民健康事业中发挥独特作用。新中国成立以来,党和政府始终关注和重视中医药和中医药文化的传承和发展。《中华人民共和国中医药法》将于今年7月1日实施,新华社记者历经6个月,走访中医界、文艺界、体育界等多领域的领军人物,就弘扬中医药和中医药文化进行调研。调研中,2015年诺贝尔生理学或医学奖、2016年度国家最高科学技术奖得主,86岁的中国中医科学院(中药研究所)终

“把论文变成药”:屠呦呦团队的新年期望

“得奖、出名都是过去的事,我们要好好‘干活’。”2018年初,出生于1930年的屠呦呦略显焦急。